RISE Life Science Announces CBD Product Distribution Arrangement for Mexico
Toronto, Ontario--(Newsfile Corp. - February 1, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") announced today that it has selected Solcanna S.A. de C.V. ("Solcanna") to act as a distributor of its Life Bloom Organics brand of CBD-based health and wellness products in Mexico.Life Bloom Organics' proprietary 'Nano' hemp extract oral sprays can be found at natural health food markets, chiropractic offices, specialty retailers and medical dispensaries in Southern...
2019-02-01 8:00 AM EST
Greg Mills Joins the Board of RISE Life Science Corp.
Toronto, Ontario--(Newsfile Corp. - January 29, 2019) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") today announced that Greg Mills, formerly Head of RBC's Global Equities, has been appointed to RISE's Board of Directors.Mr. Mills joined RBC Capital Markets in 1998 as Head of Equity Trading and in 2005 was promoted to Head of Global Equities and served in that position until 2018. Mr. Mills' key responsibilities included business planning, risk management, global P&L,...
2019-01-29 8:00 AM EST
RISE Closes Additional Tranche of Convertible Note Financing
Toronto, Ontario--(Newsfile Corp. - December 4, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") is pleased to announce that it has completed a second tranche of its offering previously announced on November 14, 2018 (the "Offering") of unsecured convertible notes (the "Notes"), raising an additional C$1,490,000. Pursuant to the Offering, the Company has now raised an aggregate of $5,525,000.The Notes will accrue interest at a rate of 12% per year, paid quarterly in cash...
2018-12-04 2:17 PM EST
RISE Closes Convertible Note Financing
Toronto, Ontario--(Newsfile Corp. - November 14, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") is pleased to announce that it has completed an unsecured convertible note (the "Notes") financing, raising an aggregate of C$4,035,000 (the "Offering").The Notes will accrue interest at a rate of 12% per year, paid quarterly in cash to the holders of the Notes. The maximum term of the Notes is 24 months. The minimum term of the Notes is twelve...
2018-11-14 1:46 PM EST
Scott Secord Joins RISE Board of Directors as Executive Chairman
Toronto, Ontario--(Newsfile Corp. - October 3, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") today announced that Scott Secord, formerly Chief Executive Officer of Gaming Nation, has been appointed to RISE's board of directors and the position of Executive Chairman.Mr. Secord served as Chief Executive Officer of Gaming Nation from June 2015 until its recent purchase by a U.S. based private equity group. Gaming Nation, formerly listed on the TSX-V, provides...
2018-10-03 8:00 AM EDT
RISE Enters Commercialization Phase with Retail Sales in California
Toronto, Ontario--(Newsfile Corp. - August 20, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") is poised for commercial success and leading the way among product and branding companies entering California, the largest cannabis market in the world, according to Bloomberg and other sources."We positioned our company for the future of this industry," commented Anton Mattadeen, CEO of RISE Life Science. "Reaching the consumer with products they love is our goal, and doing...
2018-08-20 9:06 AM EDT
RISE Welcomes Ryan Rocca as New Board Member
Toronto, Ontario--(Newsfile Corp. - August 3, 2018) - RISE Life Science Corp. (the "Company and/or "RISE") (CSE:RLSC) welcomes Ryan Rocca to its board of directors. Rocca is also named the General Manager of RISE Life Science Corp. USA and has also served as the President and Chief Executive Officer of the Cultivate Kind and Modern Marketing sister agencies, as well as Managing Partner of Life Bloom Organics.Rocca has a passion for bringing emerging brands to the consumer marketplace. In...
2018-08-03 4:42 PM EDT
RISE Closes Deal to Buy Cultivate Kind and Life Bloom Organics
Toronto, Ontario--(Newsfile Corp. - July 12, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") has completed the previously announced acquisition of 100% interest in California-based Cultivate Kind and Life Bloom Organics.The acquisition of Life Bloom Organics will immediately expand RISE's portfolio of CBD products from sexual health and wellness products to include wellness, pain and sleep products and provide access to Life Bloom's existing channels of distribution...
2018-07-12 8:30 AM EDT
RISE Life Science Corp. Announces Closing $1.4M of Equity Financing
Toronto, Ontario--(Newsfile Corp. - July 3, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") today announces that it has closed a non-brokered private placement (the "Offering") through the issuance of an aggregate of 4,824,399 units (each a "Unit") at a price of $0.30 per Unit for gross proceeds of $1,447,319.70. Each Unit is comprised of one common share ("Common Share") of the Company and one-half of one Common Share purchase warrant (each whole warrant, a...
2018-07-03 8:30 AM EDT
RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand
Toronto, Ontario--(Newsfile Corp. - June 21, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE") today announced the launch of its CBD-based wellness brand, Karezza, at retail in California as of June 20, 2018.Karezza is a suite of sexual wellness supplements that today includes a couples "In the Moment" mood support supplement, plus a "Women's Daily" supplement and a "Men's Daily" supplement that supports each gender's sexual and reproductive body systems.Each Karezza...
2018-06-21 9:22 AM EDT
RISE Life Science Provides Operational Update
Toronto, Ontario--(Newsfile Corp. - June 8, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE"), today provided an operational update on its plans and projected timelines for the 2018 calendar year. RISE is pleased to announce that it expects to launch its own commercial products for sale in the California market on or about its previously announced launch date of 6/20/2018."With the recent introduction of the RISE Report on SEX and Cannabis our longitudinal cannabis and...
2018-06-08 8:00 AM EDT
RISE Life Science Corp. to Acquire California CDB Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind
Toronto, Ontario--(Newsfile Corp. - June 7, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE") is pleased to announce that it has signed a Letter of Intent (LOI) to acquire 100% of Life Bloom Organics, LLC, a California company that produces and markets organic oral sprays containing CBD, and 100% of Cultivate Kind, one of the top marketing and branding agencies for the cannabis industry in the United States."This represents a major milestone for RISE," said RISE...
2018-06-07 8:52 AM EDT
RISE Life Science Corp. Announces the RISE Report: A Study to Explore Cannabis Use and Sexual Health
Toronto, Ontario--(Newsfile Corp. - April 24, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc.) (the "Company" and/or "RISE") today announced that it has commissioned a longitudinal study to investigate sexual function and health concerns, and, how cannabis products designed for sexual enhancement and health affect sexual behaviors and performance. The RISE Report on Cannabis and Sexual Health and Wellness (the "RISE Study") will be significant in its...
2018-04-24 8:55 AM EDT
RISE Life Science Corp. Announces Closing $2.2M of Equity Financing
Toronto, Ontario--(Newsfile Corp. - April 19, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc. (the "Company" or "RISE") is pleased to announce that, further to it press release dated March 29, 2018, it has closed tranches (each a "Tranche") of its previously announced non-brokered private placement (the "Offering") through the issuance of an aggregate of 7,366,166 units (each a "Unit") at a price of $0.30 per Unit for gross proceeds of $2,209,849.80....
2018-04-19 2:04 PM EDT
RISE Life Science Announces Private Placement of Units
Toronto, Ontario--(Newsfile Corp. - March 29, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc.) (the "Company") announces that it intends to complete a non-brokered private placement of up to 10,000,000 units ("Units") at a price of $0.30 per Unit (the "Issue Price") for gross proceeds of up to $3,000,000 (the "Offering"). Each Unit will be comprised of one common share ("Common Share") of the Company and one-half of one Common Share purchase warrant...
2018-03-29 4:23 PM EDT
RISE Life Science Corp. Changes Its Stock Symbol to RLSC
Toronto, Ontario--(Newsfile Corp. - March 13, 2018) - RISE Life Science Corp. (CSE: LMT) (formerly Luminor Medical Technologies Inc.) (the "Company") is pleased to announce that at the opening of the market on Wednesday March 14, 2018, the Company will begin trading on the Canadian Securities Exchange "CSE" under its new stock symbol: RLSC. About RISE Life Science Corp.RISE Life Science Corp. develops cutting-edge cannabis consumer products for both medical and adult-use markets around the...
2018-03-13 11:09 AM EDT
Luminor Medical Technologies Changes Its Name to RISE Life Science Corp.
Toronto, Ontario--(Newsfile Corp. - March 9, 2018) - Luminor Medical Technologies (CSE: LMT), further to the acquisition of RISE Research Inc., announced today that it changed its corporate name to RISE Life Science Corp. which was approved at the Company's annual and special shareholder meeting (the "Shareholder Meeting") held on Tuesday February 27, 2018. The Company has reserved the stock symbol "RLSC" and will commence trading under this symbol upon approval by the Canadian Securities...
2018-03-09 8:50 AM EST
Luminor Medical Technologies, RISE Research and Constance Therapeutics Announce Comprehensive Strategic Partnership
Toronto, Ontario--(Newsfile Corp. - January 30, 2018) - Luminor Medical Technologies Inc. (CSE: LMT) ("Luminor") and RISE Research Inc. ("RISE") are pleased to announce RISE's comprehensive strategic partnership with Constance Therapeutics ("CT"), an established San Francisco-based developer and manufacturer of premium medical cannabis extract products for physician and patient use in California. The partnership includes a distribution agreement that will see RISE build and manage a retail...
2018-01-30 11:29 AM EST
RISE Research and Constance Therapeutics Announce Comprehensive Strategic Partnership
Toronto, Ontario--(Newsfile Corp. - January 30, 2018) - RISE Research Inc. ("RISE") and Luminor Medical Technologies Inc. (CSE: LMT) ("Luminor") are pleased to announce RISE's comprehensive strategic partnership with Constance Therapeutics ("CT"), an established San Francisco-based developer and manufacturer of premium medical cannabis extract products for physician and patient use in California. The partnership includes a distribution agreement that will see RISE build and manage a retail...
2018-01-30 9:30 AM EST
Luminor Medical to Acquire Rise Research Inc., Licensor of the Company's Cannabis Commercial Products
Toronto, Ontario--(Newsfile Corp. - January 15, 2018) - Luminor Medical Technologies Inc. (CSE: LMT) ("the Company") is pleased to announce it has executed an agreement (the "Agreement") to acquire 100% of the issued and outstanding shares of RISE Research Inc. ("RISE", "RISE Research"). Previously, the Company held an exclusive Canadian license for cannabis-based consumer products developed by RISE Research, and now seeks to expand its participation and reach with this acquisition.All RISE...
2018-01-15 9:00 AM EST